A global Contract Research Organization (CRO) with over 30 years of experience, CMIC’s skilled researchers provide cutting-edge expertise in small and large molecule bioanalysis to optimize drug development for pharmaceutical companies. We offer bioanalysis for non-clinical and clinical projects, both GLP and non-GLP, to meet critical drug development milestones. CMIC's GLP compliant state-of-the-art facility has the capacity to accommodate quick turnaround and high-volume projects from around the country.
Specialties: Quantitative assays using HPLC, LC-MS/MS, ELISA, MSD:, Method Development, Method Transfer, Method Qualification, Method Validation, Cross Validation, and Sample Analysis
Label: pharma R&D outsourcing, Clinical, Non-Clinical, CDMO, CSO, SMO, Consulting, Orphan Drug, Patient & Healthcare Services